TROY, Mich., April 09, 2018 -- Syntel, Inc. (Nasdaq:SYNT), a leading global provider of integrated information technology and knowledge process services, today announced that it has signed a strategic partnership with Esko, a leading provider of prepress software and hardware for labeling and packaging.
Headquartered in Belgium, Esko is a leading graphic arts and digital asset management company that produces prepress software and hardware products that manage labeling, packaging design and print processes.
The partnership will allow Syntel access to Esko’s software products, training and support, and the two companies will collaborate on implementations across the U.S. and Europe. Syntel will also integrate Esko products into its existing suite of labeling and packaging solutions for the medical devices and pharmaceutical industries.
As changing regulatory requirements such as the European Union Medical Device Regulations (EU MDR) come into force, it is creating pressure on medical devices and pharmaceutical manufacturers by requiring large-scale changes to the way they create and change labels and packages of their products.
“Today’s medical devices and pharma companies must handle complex and varied international labeling standards and packaging requirements,” said Narendar G. Reddy, Syntel Vice President and Life Sciences Business Unit Head. “Our solutions are delivered in a unique, automation-driven managed or shared services model that enables clients to respond to a fast changing marketplace and stay compliant at all times with the highest possible quality.”
Syntel’s labeling and packaging services are designed to reduce waste, eliminate product recalls, bring products to market faster, and ensure consistent branding all the way from the factory to the consumer.
“We believe that partnering with Esko will strengthen our services by enabling us to provide integrated IT and process support for Esko’s industry-leading products, making it easier for our clients to achieve the visibility and flexibility that today’s life sciences industry demands,” said Reddy.
More information about Syntel’s labeling and packaging services for life sciences is available at https://www.syntelinc.com/industries/life-sciences/medical-devices/labeling-and-packaging
About Syntel
Syntel (Nasdaq:SYNT) is a leading global provider of integrated information technology and knowledge process services. Syntel helps global enterprises evolve the core by leveraging automation, scaled agile and cloud platforms to build efficient application development and management, testing and infrastructure solutions. Syntel’s digital services enable companies to engage customers, discover new insights through analytics, and create a more connected enterprise through the internet of things. Syntel’s "Customer for Life" philosophy builds collaborative partnerships and creates long-term client value by investing in IP, solutions and industry-focused delivery teams with deep domain knowledge.
To learn more, visit us at www.syntelinc.com.
Contacts:
North America/Europe: Jon Luebke, Syntel, 248/619-3503, [email protected]


Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 



